Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1990 Jun;64(6):2788–2795. doi: 10.1128/jvi.64.6.2788-2795.1990

Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.

A Yasuda 1, J Kimura-Kuroda 1, M Ogimoto 1, M Miyamoto 1, T Sata 1, T Sato 1, C Takamura 1, T Kurata 1, A Kojima 1, K Yasui 1
PMCID: PMC249459  PMID: 2159544

Abstract

A cDNA clone representing the genome of structural proteins of Japanese encephalitis virus (JEV) was inserted into the thymidine kinase gene of vaccinia virus strains LC16mO and WR under the control of a strong early-late promoter for the vaccinia virus 7.5-kilodalton polypeptide. Indirect immunofluorescence and fluorescence-activated flow cytometric analysis revealed that the recombinant vaccinia viruses expressed JEV E protein on the membrane surface, as well as in the cytoplasm, of recombinant-infected cells. In addition, the E protein expressed from the JEV recombinants reacted to nine different characteristic monoclonal antibodies, some of which have hemagglutination-inhibiting and JEV-neutralizing activities. Radioimmunoprecipitation analysis demonstrated that two major proteins expressed in recombinant-infected cells were processed and glycosylated as the authentic PreM and E glycoproteins of JEV. Inoculation of rabbits with the infectious recombinant vaccinia virus resulted in rapid production of antiserum specific for the PreM and E glycoproteins of JEV. This antiserum had both hemagglutination-inhibiting and virus-neutralizing activities against JEV. Furthermore, mice vaccinated with the recombinant also produced JEV-neutralizing antibodies and were resistant to challenge with JEV.

Full text

PDF
2788

Images in this article

2791Image
on p.2791
2792Image
on p.2792
2793Image
on p.2793
2793Image
on p.2793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennink J. R., Yewdell J. W., Smith G. L., Moller C., Moss B. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature. 1984 Oct 11;311(5986):578–579. doi: 10.1038/311578a0. [DOI] [PubMed] [Google Scholar]
  2. Bray M., Zhao B. T., Markoff L., Eckels K. H., Chanock R. M., Lai C. J. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. J Virol. 1989 Jun;63(6):2853–2856. doi: 10.1128/jvi.63.6.2853-2856.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cochran M. A., Puckett C., Moss B. In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals. J Virol. 1985 Apr;54(1):30–37. doi: 10.1128/jvi.54.1.30-37.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deubel V., Kinney R. M., Esposito J. J., Cropp C. B., Vorndam A. V., Monath T. P., Trent D. W. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol. 1988 Aug;69(Pt 8):1921–1929. doi: 10.1099/0022-1317-69-8-1921. [DOI] [PubMed] [Google Scholar]
  5. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  6. Kieny M. P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J. P. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984 Nov 8;312(5990):163–166. doi: 10.1038/312163a0. [DOI] [PubMed] [Google Scholar]
  7. Kimura-Kuroda J., Yasui K. A focus assay method for Japanese encephalitis virus using complement and anti-virus serum. Microbiol Immunol. 1985;29(1):55–63. doi: 10.1111/j.1348-0421.1985.tb00802.x. [DOI] [PubMed] [Google Scholar]
  8. Kimura-Kuroda J., Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J Gen Virol. 1986 Dec;67(Pt 12):2663–2672. doi: 10.1099/0022-1317-67-12-2663. [DOI] [PubMed] [Google Scholar]
  9. Kimura-Kuroda J., Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol. 1988 Nov 15;141(10):3606–3610. [PubMed] [Google Scholar]
  10. Kimura-Kuroda J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol. 1983 Jan;45(1):124–132. doi: 10.1128/jvi.45.1.124-132.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kitano T., Suzuki K., Yamaguchi T. Morphological, chemical, and biological characterization of Japanese encephalitis virus virion and its hemagglutinin. J Virol. 1974 Sep;14(3):631–639. doi: 10.1128/jvi.14.3.631-639.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. MORI H., NAKAI H., NOZIMA T. THE INTERACTION OF JAPANESE ENCEPHALITIS VIRUS WITH ITS RECEPTOR PREPARED FROM PIGEON RED BLOOD CELLS AND SUSCEPTIBLE CELLS. Acta Virol. 1965 Mar;9:97–108. [PubMed] [Google Scholar]
  14. Mackett M., Smith G. L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol. 1984 Mar;49(3):857–864. doi: 10.1128/jvi.49.3.857-864.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mackett M., Yilma T., Rose J. K., Moss B. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science. 1985 Jan 25;227(4685):433–435. doi: 10.1126/science.2981435. [DOI] [PubMed] [Google Scholar]
  16. Matsuura Y., Miyamoto M., Sato T., Morita C., Yasui K. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology. 1989 Dec;173(2):674–682. doi: 10.1016/0042-6822(89)90580-1. [DOI] [PubMed] [Google Scholar]
  17. McAda P. C., Mason P. W., Schmaljohn C. S., Dalrymple J. M., Mason T. L., Fournier M. J. Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology. 1987 Jun;158(2):348–360. doi: 10.1016/0042-6822(87)90207-8. [DOI] [PubMed] [Google Scholar]
  18. Morita M., Suzuki K., Yasuda A., Kojima A., Sugimoto M., Watanabe K., Kobayashi H., Kajima K., Hashizume S. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain. Vaccine. 1987 Mar;5(1):65–70. doi: 10.1016/0264-410x(87)90012-0. [DOI] [PubMed] [Google Scholar]
  19. Moss B., Flexner C. Vaccinia virus expression vectors. Annu Rev Immunol. 1987;5:305–324. doi: 10.1146/annurev.iy.05.040187.001513. [DOI] [PubMed] [Google Scholar]
  20. Moss B., Smith G. L., Gerin J. L., Purcell R. H. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature. 1984 Sep 6;311(5981):67–69. doi: 10.1038/311067a0. [DOI] [PubMed] [Google Scholar]
  21. Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn. 1988 Apr;30(2):175–184. doi: 10.1111/j.1442-200x.1988.tb02516.x. [DOI] [PubMed] [Google Scholar]
  22. Paoletti E., Lipinskas B. R., Samsonoff C., Mercer S., Panicali D. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A. 1984 Jan;81(1):193–197. doi: 10.1073/pnas.81.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Perkus M. E., Piccini A., Lipinskas B. R., Paoletti E. Recombinant vaccinia virus: immunization against multiple pathogens. Science. 1985 Sep 6;229(4717):981–984. doi: 10.1126/science.2992092. [DOI] [PubMed] [Google Scholar]
  24. Sanger F., Coulson A. R., Barrell B. G., Smith A. J., Roe B. A. Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol. 1980 Oct 25;143(2):161–178. doi: 10.1016/0022-2836(80)90196-5. [DOI] [PubMed] [Google Scholar]
  25. Shapiro D., Brandt W. E., Cardiff R. D., Russell P. K. The proteins of Japanese encephalitis virus. Virology. 1971 Apr;44(1):108–124. doi: 10.1016/0042-6822(71)90158-9. [DOI] [PubMed] [Google Scholar]
  26. Shapiro D., Kos K. A., Russel P. K. Japanese encephalitis virus glycoproteins. Virology. 1973 Nov;56(1):88–94. doi: 10.1016/0042-6822(73)90289-4. [DOI] [PubMed] [Google Scholar]
  27. Smith G. L., Mackett M., Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 1983 Apr 7;302(5908):490–495. doi: 10.1038/302490a0. [DOI] [PubMed] [Google Scholar]
  28. Sugimoto M., Yasuda A., Miki K., Morita M., Suzuki K., Uchida N., Hashizume S. Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains. Microbiol Immunol. 1985;29(5):421–428. doi: 10.1111/j.1348-0421.1985.tb00843.x. [DOI] [PubMed] [Google Scholar]
  29. Sumiyoshi H., Mori C., Fuke I., Morita K., Kuhara S., Kondou J., Kikuchi Y., Nagamatu H., Igarashi A. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology. 1987 Dec;161(2):497–510. doi: 10.1016/0042-6822(87)90144-9. [DOI] [PubMed] [Google Scholar]
  30. Sumiyoshi H., Morita K., Mori C., Fuke I., Shiba T., Sakaki Y., Igarashi A. Sequence of 3000 nucleotides at the 5' end of Japanese encephalitis virus RNA. Gene. 1986;48(2-3):195–201. doi: 10.1016/0378-1119(86)90077-6. [DOI] [PubMed] [Google Scholar]
  31. Trent D. W. Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing. J Virol. 1977 Jun;22(3):608–618. doi: 10.1128/jvi.22.3.608-618.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Trent D. W., Harvey C. L., Qureshi A., LeStourgeon D. Solid-phase radioimmunoassay for antibodies to flavivirus structural and nonstructural proteins. Infect Immun. 1976 May;13(5):1325–1333. doi: 10.1128/iai.13.5.1325-1333.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Watanabe K., Kobayashi H., Kajiyama K., Morita M., Yasuda A., Gotoh H., Saeki S., Sugimoto M., Saito H., Kojima A. Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen. Vaccine. 1989 Feb;7(1):53–59. doi: 10.1016/0264-410x(89)90011-x. [DOI] [PubMed] [Google Scholar]
  34. Wiktor T. J., Macfarlan R. I., Reagan K. J., Dietzschold B., Curtis P. J., Wunner W. H., Kieny M. P., Lathe R., Lecocq J. P., Mackett M. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7194–7198. doi: 10.1073/pnas.81.22.7194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zhao B. T., Prince G., Horswood R., Eckels K., Summers P., Chanock R., Lai C. J. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J Virol. 1987 Dec;61(12):4019–4022. doi: 10.1128/jvi.61.12.4019-4022.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES